CIK 0001674632 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Beta Bionics, Inc.
Sign in to watch- Ticker
- BBNX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475386878
- Phone
- 949-427-7785
- Business address
- 11 HUGHES, IRVINE, CA, 92618
- Former names
- Beta Bionics, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,285,734
- in 20 filings, $2.5M under 10b5-1 plans
Net −$3,285,734. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-13 | Dearen Danny L. Director | Grant or award | +3,997 | 15,244 | ||
| 2026-01-13 | CARNEY SEAN Director | Grant or award | +3,997 | 15,244 | ||
| 2026-01-13 | MICHEL GERARD J Director | Grant or award | +3,997 | 16,544 | ||
| 2026-01-06 | Mensinger Mike Chief Product Officer | Sale 10b5-1 | −2,200 | $30.10 | $66K | 80,752 |
| 2026-01-02 | Feider Stephen Chief Financial Officer | Option exercise 10b5-1 | +20,000 | $5.10 | $102K | 62,614 |
| 2026-01-02 | Feider Stephen Chief Financial Officer | Sale 10b5-1 | −20,000 | $29.53 | $591K | 42,614 |
| 2026-01-02 | Feider Stephen Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −20,000 | 49,695 | ||
| 2026-01-02 | Mensinger Mike Chief Product Officer | Sale 10b5-1 | −7,200 | $29.56 | $213K | 83,552 |
| 2026-01-02 | Mensinger Mike Chief Product Officer | Sale 10b5-1 | −600 | $30.20 | $18K | 82,952 |
| 2025-12-04 | Hopman Mark Chief Commercial Officer | Sale 10b5-1 | −2,061 | $30.66 | $63K | 136,216 |
| 2025-12-02 | Russell Steven Jon Chief Medical Officer | Sale | −1,025 | $29.34 | $30K | 178,071 |
| 2025-12-02 | Hopman Mark Chief Commercial Officer | Sale 10b5-1 | −856 | $29.34 | $25K | 138,277 |
| 2025-12-02 | Saint Sean President & CEO | Sale | −3,278 | $29.34 | $96K | 97,924 |
| 2025-12-02 | Feider Stephen Chief Financial Officer | Sale | −1,427 | $29.34 | $42K | 42,614 |
| 2025-12-02 | Mensinger Mike Chief Product Officer | Sale | −1,063 | $29.34 | $31K | 90,752 |
| 2025-12-01 | Lezack Adam Director | Sale 10b5-1 | −906 | $29.35 | $27K | 8,935 |
| 2025-12-01 | Lezack Adam Director | Sale 10b5-1 | −500 | $29.91 | $15K | 8,435 |
| 2025-12-01 | Palasis Maria Director | Sale 10b5-1 | −906 | $29.33 | $27K | 8,935 |
| 2025-12-01 | Palasis Maria Director | Sale 10b5-1 | −500 | $29.96 | $15K | 8,435 |
| 2025-10-31 | Lezack Adam Director | Sale 10b5-1 | −1,368 | $26.85 | $37K | 9,879 |
Page 5 of 11 · 210 trades